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Background: Recent studies suggested that cardiac conduction in murine hearts with
narrow perinexi and 50% reduced connexin43 (Cx43) expression is more sensitive to
relatively physiological changes of extracellular potassium ([K+]o) and sodium ([Na
+]o).
Purpose: Determine whether similar [K+]o and [Na
+]o changes alter conduction velocity
(CV) sensitivity to pharmacologic gap junction (GJ) uncoupling in guinea pigs.
Methods: [K+]o and [Na
+]o were varied in Langendorff perfused guinea pig ventricles
(Solution A: [K+]o = 4.56 and [Na
+]o = 153.3mM. Solution B: [K
+]o = 6.95 and
[Na+]o = 145.5mM). Gap junctions were inhibited with carbenoxolone (CBX) (15 and
30µM). Epicardial CV was quantified by optical mapping. Perinexal width was measured
with transmission electron microscopy. Total and phosphorylated Cx43 were evaluated
by western blotting.
Results: Solution composition did not alter CV under control conditions or with 15µM
CBX. Decreasing the basic cycle length (BCL) of pacing from 300 to 160ms decreased
CV uniformly with both solutions. At 30µM CBX, a change in solution did not alter
CV either longitudinally or transversely at BCL = 300ms. However, reducing BCL to
160ms caused CV to decrease more in hearts perfused with Solution B than A. Solution
composition did not alter perinexal width, nor did it change total or phosphorylated serine
368 Cx43 expression. These data suggest that the solution dependent CV changes were
independent of altered perinexal width or GJ coupling. Action potential duration was
always shorter in hearts perfused with Solution B than A, independent of pacing rate
and/or CBX concentration.
Conclusions: Increased heart rate and GJ uncoupling can unmask small CV differences
caused by changing [K+]o and [Na
+]o. These data suggest that modulating extracellular
ionic composition may be a novel anti-arrhythmic target in diseases with abnormal GJ
coupling, particularly when heart rate cannot be controlled.
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INTRODUCTION
Normal cardiac conduction is critical for maintaining efficient
pumping of the heart, and abnormal conduction can lead to
arrhythmias and sudden cardiac death. Cardiac conduction
is dependent on propagation of electrical signals from cell-
to-cell. Cell membrane depolarization can occur by raising
the intracellular potential via direct axial current through
high resistance gap junctions (gap junctional coupling), or by
decreasing the extracellular potential between closely adjacent
cells (ephaptic coupling) (Kucera et al., 2002; Sperelakis and
McConnell, 2002; Mori et al., 2008; Veeraraghavan et al.,
2012, 2014). The concept of ephaptic coupling (EpC) is an
old theory that has received renewed interest recently. While
considered controversial in the cardiac field, EpC is more widely
accepted in neurology (Bokil et al., 2001; Anastassiou et al.,
2011; Su et al., 2012; Van der Goes van Naters, 2013; Maïna
et al., 2015) and has even been proposed to be important
for uterine contraction (Young, 2007). An elegant review by
Nicholas Sperelakis and Keith McConnell in 2002 summarizes 6
possible mechanisms for EpC (Sperelakis and McConnell, 2002).
Despite the many proposed mechanisms, the most prominent
computational descriptions of EpC are electric field coupling
(Rohr et al., 1998; Sperelakis and McConnell, 2002; Lin and
Keener, 2010), or a combination of electric field coupling and the
alteration of ionic concentrations within restricted extracellular
microdomains (Mori et al., 2008; Hand and Peskin, 2010; Lin
and Keener, 2010, 2013, 2014). Importantly, EpC is a theoretical
parallel pathway to gap junction (GJ) mediated cell-to-cell
electrical coupling.
Recent evidence in guinea pig ventricular myocardium
(Veeraraghavan et al., 2012) demonstrates that inducing
acute interstitial edema can increases intercellular separation
within the perinexal intercalated disc microdomain and slow
cardiac conduction bymechanisms consistent withmathematical
predictions of EpC (Lin and Keener, 2010, 2013, 2014).
Further, increasing perinexal width hypersensitizes myocardial
conduction to pharmacologic GJ uncoupling (Veeraraghavan
et al., 2012) and sodium channel inhibition (Veeraraghavan et al.,
2015). This hypersensitivity is also consistent with computational
predictions of EpC. Importantly, the corollary statement is that
narrowing intercellular separation within the perinexus should
decrease conduction sensitivity to GJ uncoupling and sodium
channel inhibition.
In mice, we previously demonstrated that the relationships
between cardiac conduction and GJs, perinexal width, and
extracellular concentrations of sodium ([Na+]o) and potassium
([K+]o) are complex (George et al., 2015). Since it has also been
shown that a change in [K+]o from 5 to 8mM increased CV
in guinea pig hearts (Kagiyama et al., 1982; Buchanan et al.,
1985), one would expect a similar increase in mice. However, in
mouse hearts with the native compliment of Cx43 (wild type),
and wide perinexi (>15 nm), cardiac conduction was reduced
when [K+]o was raised from 4.6 to 6.1mM and concurrently
[Na+]o was decreased from 155 to 147mM. More intriguing
was the finding that the wild type hearts were insensitive to
the same changes of [K+]o and [Na
+]o when perinexal width
was reduced. However, when Cx43 was reduced by 50%, hearts
with narrow perinexi perfused with a solution containing the
higher [K+]o and lower [Na
+]o had slower conduction relative
to the solution with lower [K+]o and higher [Na
+]o. Therefore,
the width of the perinexus has important effects on modulating
cardiac conduction sensitivity to alterations in [K+]o and [Na
+]o,
and these effects are unmasked by GJ uncoupling.
Importantly, the relationship between conduction and
perinexal width does not appear to be species dependent as
similar findings were observed in guinea pig (Veeraraghavan
et al., 2015). However, it remains unknown whether small
extracellular changes in [K+]o and [Na
+]o can alter conduction
sensitivity to pharmacologic GJ coupling in guinea pig.
The purpose of this study was twofold. First, we wanted
to determine if the observed response of cardiac conduction
to [K+]o and [Na
+]o is similar in normal guinea pig hearts
as was observed in Cx43 wild type mouse hearts with
narrow perinexi. Second, we sought to demonstrate that
pharmacologically uncoupling GJs with a non-specific GJ
uncoupler like carbenoxolone (CBX) would unmask conduction
sensitivity to [K+]o and [Na
+]o in guinea pig hearts with narrow
perinexi.
MATERIALS AND METHODS
This study abides by and follows all guidelines set forth by
the Institutional Animal Care and Use Committee at Virginia
Polytechnic Institute and State University and NIH Guide for the
Care and Usage of Laboratory Animals.
Langendorff Perfusion
Male retired breeder Hartley albino guinea pigs (Hilltop,
Scottdale, PA, N = 28, 800–1200 g, 12–19 months old) were
anesthetized using sodium pentobarbital [Nembutal, 30mg/kg
IP]. The heart was extracted, retrogradely perfused in a
Langendorff perfusion apparatus and the atria excised to reduce
competitive stimulation. The hearts were perfused with constant
flow to maintain pressure between 40 and 55mm Hg. Tyrode’s
solutions were altered as described in Table 1. The laboratory’s
historical Tyrode’s composition in Table 1 is presented as a point
of reference for the modified solutions used in these experiments.
Since “normal” plasma ion concentrations are species specific
(UoM, 2009), we calculated a percentage change of [K+]o and
[Na+]o from the lowest values used in our previous mouse study
(George et al., 2015). Thus, [K+]o was changed in this study by
52% (4.56–6.95mM) and [Na+]o by 5.4% (145.5 to 153.3mM)
from historic guinea pig Tyrode’s solutions (Veeraraghavan et al.,
2012). By this method, we designed Solutions A and B as noted
in Table 1.
Solutions were perfused at 37◦C, pH 7.4. In each experiment,
historic laboratory Tyrode’s solution without the gap junction
uncoupler CBX was perfused for 30min at the beginning of the
experiment, and then Solutions A and B were perfused for 10min
in a random order without CBX. This was followed by CBX (15
and 30µM) in Solution A or B.
All conduction measurements were taken 10min after the
new perfusate reached the heart to control for the amount of
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TABLE 1 | Modified Tyrode’s solution compositions (mM).
Historical Solution A Solution B
GP Tyrode’s solution (mmol/L)
NaCl 140 147.8 140
NaOH 5.5 5.5 5.5
Total [Na+] 145.5 153.3 145.5
KCl 4.56 4.56 6.95
Total [K+] 4.56 4.56 6.95
CaCl2 1.25 1.25 1.25
Dextrose 5.5 5.5 5.5
MgCl2 0.7 0.7 0.7
HEPES 10 10 10
BDM 7.5 7.5 7.5
time each heart was exposed to the solution, and because we
previously demonstrated CBX slowed conduction to near steady-
state values within 10min (Veeraraghavan et al., 2015). Hearts
were paced from the anterior left ventricular (LV) epicardium
with a unipolar AgCl wire at basic cycle lengths (BCL) of 300
and 160ms with a 5ms pulse at 1.5 times pacing threshold
(Veeraraghavan et al., 2013). A baseline BCL of 300ms was
chosen to mimic physiological resting guinea pig heart rate, while
160ms BCL has been shown to decrease CV (Girouard et al.,
1996; Akar et al., 2000; Lou et al., 2012).
Transmission Electron Microscopy
Left ventricular tissue from each intervention reported (3 hearts
per intervention, 3 samples per heart) was sectioned into 1mm3
cubes. The sections were fixed in 2.5% glutaraldehyde at 4◦C
overnight and then transferred to PBS at 4◦C. The tissue was
processed as previously described (George et al., 2015). Images
were collected using a transmission electron microscope (JEOL
JEM1400) at 150,000 X magnification. Measurements were
obtained using ImageJ (NIH) from 15 perinexi per sample. Total
number of perinexi measured was 135.
Optical Mapping
The voltage sensitive dye di-4-ANEPPS (15µM) was perfused
for 10min before the start of the experimental protocol. Cardiac
motion was reduced with 2,3-butanedione monoxime (BDM,
7.5mM). Hearts were further stabilized by applying light pressure
on the posterior surface of the heart.
The dye was excited with a halogen light source (MHAB-
150 W, Moritex Corporation) with an excitation filter of 510 nm
(Brightline Fluorescence Filter). An emission filter of 610 nm
[610FG01-50(T257), Andover Corporation] was used before the
emitted light was recorded using a MiCam Ultima CMOS L-
camera (SciMedia), sampling at a rate of 1 kHz. Images were
captured on a 100 × 100 array with an inter-pixel resolution of
0.1mm.
CV was calculated as previously described (George et al.,
2015) using an algorithm by Bayly et al. (1998). Briefly,
maximum rate of optical action potential rise at each pixel
was calculated to determine activation time. A parabolic surface
was fit to activation times to determine vectors for CV at each
pixel. CV was quantified in two directions, longitudinal and
transverse (CVL and CVT, respectively), with anisotropic ratio
(AR) calculated as CVL/CVT. Conduction in each direction was
calculated from a group of vectors that were within 5 pixels and
with an angle of ±8◦ from direction of longitudinal (fastest) or
transverse (slowest) propagation. The first vectors immediately
adjacent to the site of pacing were excluded to reduce pacing
artifacts in the CV analysis. CV was only quantified up to 32
pixels from the site of pacing in the longitudinal direction and
16 pixels in the transverse direction to reduce the contribution of
conduction breakthrough. Longitudinal CV was only quantified
if there were at least 10 vectors meeting the criteria above and
transverse CV was quantified if at least 50 vectors met the criteria
above.
Rise time (RT) was calculated by the time difference from
20 to 80% of the peak fluorescent action potential amplitude
during depolarization. RT was calculated both in the longitudinal
(RTL) and transverse (RTT) directions. Action potential duration
(APD) was calculated as the difference between the activation
time and 85% repolarization from peak action potential
amplitude.
Western Blotting
Hearts (n = 3), perfused with respective solutions for 30min,
were snap frozen. Tissue was homogenized in a RIPA lysis
buffer (50mM Tris pH 7.4, 150mM NaCl, 1mM EDTA, 1%
Triton X-100, 1% sodium deoxycholate, 2mM NaF, 200µM
Na3VO4) supplemented with HALT Protease and Phosphatase
Inhibitor Cocktail (ThermoScientific). Following sonication and
clarification by centrifugation, the BioRad DC protein assay was
employed to determine and normalize protein concentrations
prior to analysis. SDS-PAGE electrophoresis was performed as
previously described using 4–20%NuPage Bis-Tris or 3–8% Tris-
Acetate gels (Life Technologies) which were then transferred
using the Trans-Blot Turbo system (BioRad) to low-fluorescence
PVDF membrane and blocked with 5% BSA in TNT buffer
(0.1% Tween 20, 150mM NaCl, 50mM Tris pH 8.0) for 1 h
at room temperature. Membranes were then incubated with
rabbit anti-phospho-Cx43Ser368 (1:1000 in 5% BSA TNT, #3511
Cell Signaling Technology) overnight at 4◦C. Following several
washes in TNT, secondary detection was performed using goat
anti-rabbit HRP antibody (1:5000, abcam) for 1 h at room
temperature. Bound antibody was detected post washing using
Clarity Western ECL Substrate (BioRad) and imaged using the
BioRad Chemidoc MP system. Membranes were then stripped
with Re-Blot Plus Strong (Millipore) according to manufacturer’s
instructions. To detect total Cx43, stripped membranes were
blocked for 1 h at room temperature in 5% milk in TNT buffer,
and subsequently incubated overnight at 4◦C with primary
antibodies against Cx43 (1:4000, C6219 rabbit, Sigma Aldrich),
and alpha-tubulin (1:4000, T6199 mouse, Sigma-Aldrich) diluted
in 5% milk TNT. Membranes were then washed and incubated
with the fluorescently distinct secondary antibodies goat anti-
mouse AlexaFluor555 and goat anti-rabbit AlexaFlour647 (both
1:1000 in milk TNT, Life Technologies) for 1 h at room
temperature. Following several washes in TNT, membranes were
fixed in methanol, dried, and imaged using the Biorad Chemidoc
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MP System. Protein expression was quantified by densitometry
using ImageLab software (BioRad), Cx43 expression levels were
normalized to alpha-tubulin, and Cx43 phosphorylate Serine 368
(Cx43-p368S) to total Cx43.
Statistics Analysis
Statistical analysis was performed using a two tailed Student’s
t-test for both paired and unpaired data. A p ≤ 0.025 after
Bonferrroni correction was considered significant. All values are
reported as mean± standard error unless otherwise noted.
RESULTS
Conduction Velocity—Control Conditions
(0 µM Carbenoxolone)
Cardiac conduction was quantified from guinea pig ventricles
to determine whether increasing [K+]o and decreasing [Na
+]o
produced similar effects in ex vivo guinea pig as it did in mice
hearts (George et al., 2015). Representative epicardial isochrones
in Figure 1A demonstrate the effect of solution composition on
the spatial extent of epicardial activation at both 300 and 160ms
BCL. These maps suggest that cardiac conduction under control
conditions was similar when hearts were perfused with Solution
A or B. Further, representative isochrones maps suggest that
reducing BCL decreases CVL and CVT, consistent with sodium
channel restitution kinetics (Allouis et al., 2006). Representative
action potential upstrokes in Figure 1B from equally spaced sites
demonstrate slower CVT than CVL as evidenced by increased
temporal separation between action potential upstrokes in the
transverse direction.
Reducing BCL significantly decreased CVL for both Solutions
A and B (Figure 1C). Interestingly, reducing BCL to 160ms with
Solution A did not decrease CVT, although a trend was observed
(p = 0.03). On the other hand, changing BCL with Solution
B caused a significant decrease in CVT. For all experiments,
solution composition did not significantly change CVL or CVT
under control conditions (Figure 1D). These data suggest that
solution composition does not significantly modulate conduction
dependence on pacing rate with normal GJ coupling, because
both solutions changed CV similarly under all conditions.
Conduction Velocity—15 µM
Carbenoxolone
We previously demonstrated that GJ inhibition with 15µM
CBX does not significantly alter CV (Veeraraghavan et al.,
2012). For Solution A + 15µM CBX, reducing BCL to 160ms
significantly decreased CVL but did not significantly decrease
CVT (Figure 2A). Under these conditions the relationship did
not trend toward significance (p = 0.70) in contrast to control.
Similar to control, reducing BCL from 300 to 160ms still
decreased CVL and CVT in hearts perfused with Solution
B (Figure 2A). Importantly, comparing CVL and CVT for
Solutions A and B did not reveal conduction differences when
hearts were perfused with 15µM CBX at either pacing rate
(Figure 2B), and this is similar to findings under control
conditions. These data suggest that solution composition
FIGURE 1 | Pacing rate but not solution composition alters CV in
hearts with normal GJ coupling. (A) Representative isochrones from hearts
perfused without CBX, showing conduction slowing between pacing rates, but
not solutions. (B) Uniformly spaced action potential upstrokes from the same
hearts as pictured in (A), demonstrating temporal upstroke separation as
another indicator of decreased CV. (C) Black symbols: 300ms BCL, Gray
symbols: 160ms BCL. CV measurements for longitudinal and transverse
directions. CV decreased due to increased pacing rate for each combination
except Solution A in the transverse direction. (D) Percent changes in CVL and
CVT between Solutions A and B show no changes in CV due to
perfusate. *p < 0.025 between pacing rates.
does not significantly modulate conduction dependence on
pacing rate when a GJ uncoupler does not measurably slow
conduction.
Conduction Velocity—30 µM
Carbenoxolone
Next, we increased CBX to 30µM since it has been previously
demonstrated that CBX between 20 and 100µMcan slow cardiac
conduction (Spray et al., 2006). For Solution A + 30µM CBX,
reducing BCL from 300 to 160ms did not significantly decrease
CVL but it did decrease CVT (Figure 3A).
Similar to control and 15µMCBX, CVL and CVT significantly
decreased when BCL was reduced to 160ms in hearts perfused
with Solution B + 30µM CBX (Figure 3A). Thus, rapid pacing,
in hearts perfused with Solution B, decreased CV in both
the longitudinal and transverse direction for all degrees of GJ
Frontiers in Physiology | www.frontiersin.org 4 February 2016 | Volume 7 | Article 16
Entz et al. Sodium, Potassium, Gap Junctions
FIGURE 2 | Conduction in hearts perfused with 15 µM CBX. (A) Black
symbols: 300ms BCL, Gray symbols: 160ms BCL. Effects of BCL on CVL
and CVT. (B) Percent changes in CVL and CVT between Solutions A and B.
Solution did not change CV at 15 µM CBX. *p < 0.025 between pacing rates.
uncoupling, whereas the same was not true for hearts perfused
with Solution A.
Similar to conditions above, the change in CVL and CVT
between Solutions A and B were not significant at 300ms BCL
(Figure 3B) with 30µM CBX. However, Solution B decreased
CVL and CVT significantly more than Solution A at 160ms
BCL (Figure 3B, †). These data demonstrate that significant GJ
uncoupling can exacerbate CV dependent differences on [K+]o
and [Na+]o when pacing rate is increased.
Perinexal Width
The perinexus is defined as the extracellular microdomain
immediately adjacent to GJ plaques, and these microdomains,
rich in the cardiac isoform of the voltage gated sodium channel,
have been proposed as the structural unit of a cardiac ephapse
(Rhett et al., 2013; George et al., 2015; Veeraraghavan et al.,
2015). Using transmission electron microscopy, the perinexus
was quantified from hearts perfused with Solution A, Solution A
+ CBX 30µM, and Solution B + CBX 30µM (Figure 4A). The
yellow shaded region in the images represents the first 150 nm
of the perinexus adjacent to a GJ plaque. The intermembrane
widths of perinexi were measured in 5 nm increments for the
first 15 nm and then in 15 nm intervals up to150 nm away
from the GJ (Figure 4B). Perinexal width was significantly larger
with Solution A alone when compared to tissue perfused with
CBX (Solution A or B). With CBX, there were no significant
differences in perinexal width between Solutions A and B as
summarized in Figure 4C. The data also demonstrates that
the perinexal width from 60 to 105 nm is reduced by CBX
independent of solution composition. Therefore, the difference
in CV observed between Solutions A and B at 30µM CBX is not
likely related to solution induced perinexal differences.
FIGURE 3 | Conduction in hearts perfused with 30µM CBX. (A) Black
symbols: 300ms BCL, Gray symbols: 160ms BCL. Effects of BCL on CVL
and CVT. (B) Percent changes in CVL and CVT between Solutions A and B.
Solution B decreases CVL and CVT more than Solution A at 160ms BCL with
30µM CBX. *p < 0.025 between pacing rates. †p < 0.025 between Solutions
A and B.
Cx43 Expression
Many studies have demonstrated that CV is dependent on
ionic perfusate composition (Kishida et al., 1979; Kagiyama
et al., 1982; Pressler et al., 1982). We sought to determine
whether the reported changes in perfusate composition can
also alter Cx43 expression. Expression levels of total and Cx43-
p368S were measured using alpha-tubulin as a protein loading
control in hearts perfused for 30min with Solution A or B.
Figures 5A,B demonstrate that solution composition did not
alter total Cx43 expression. Dephosphorylation at serine 368
leads to a cascade which internalizes Cx43 in cardiac cells (Smyth
et al., 2014), and Cx43-p368S protein levels are often quantified
as a correlate of non-functional Cx43 GJs (Hund et al., 2007;
Palatinus et al., 2011). Importantly, Cx43-p368S expression levels
were not different in preparations perfused with Solution A or B
(Figures 5C,D). In a separate set of experiments, Cx43-p368S was
compared to total Cx43 in hearts perfused with Solutions A or
B, and freshly explanted hearts, revealing that perfusion did not
alter the ratio of phosphorylated Cx43 (Supplemental Figure 1).
These data suggest that solution associated conduction changes
were not predominantly due to Cx43 expression changes.
Action Potential Duration
APD during perfusion of Solution B was shorter than in hearts
perfused with Solution A for all CBX concentrations and BCLs
(Figure 6, †). As expected, APD significantly shortened with
both solutions when BCL was reduced from 300 to 160ms
(Figure 6, ∗). Since APD shortened approximately equally with
Solutions A and B, and the magnitude of APD shortening was
similar, these data suggest that APD restitution kinetics may not
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FIGURE 4 | CBX decreases perinexal width. (A) Representative transmission electron microscopy images of the edge of a GJ plaque and the perinexus
(highlighted in yellow). (B) Perinexal width as a function of distance from the GJ plaque. CBX decreases intercellular separation between 60 and 105 nm from the GJ.
(C) Summary Data between 60 and 105 nm from the GJ plaque. *p < 0.025 from Solution A.
explain the changes in CV reported above. In fact, one might
expect that Solution A, which produced the longer APD, would
decrease CV more at a 160ms BCL, and this was not the case.
Rise Time
Optical rise time (RT) has been previously used as an inverse
correlate of cellular excitability (Spach et al., 1981; Poelzing and
Rosenbaum, 2004; Poelzing et al., 2004). Importantly, 15µM
CBX did not significantly alter RT relative to control (Figure 7).
With 30µM CBX however, RT significantly increased (Figure 7,
†). In contrast, solution composition did not significantly alter
RT. Altering pacing rate also did not significantly change RT in
either the longitudinal (RTL) or transverse (RTT) directions of
propagation.
DISCUSSION
The data demonstrate how varying [K+]o, [Na
+]o, and pacing
rate modulates conduction sensitivity to pharmacologic GJ
inhibition in guinea pig ventricular preparations. Previous
studies have demonstrated that each of these factors can affect
CV individually, but that small combined changes in these
parameters can lead to relatively significant emergent effects on
conduction (Buchanan et al., 1985; de Groot et al., 2003; George
et al., 2015; Veeraraghavan et al., 2015). The present study is
consistent with these finding and supports a hypothesis that
small differences in artificial blood substitute solutions do not
produce significant electrophysiological differences with normal
GJ coupling. However, when GJ coupling is reduced, extracellular
ionic composition and heart rate have important effects on
cardiac conduction.
Effects of [K+]o and [Na
+]o
The relationship between CV and [K+]o is biphasic. Specifically,
in guinea pig, it was demonstrated that CV is maximal around
8mM [K+]o (Kagiyama et al., 1982; Buchanan et al., 1985;
Veenstra et al., 1987; Nygren and Giles, 2000). Interestingly,
increasing [K+]o from 4.6mM in Solution A to 7.0mM with
Solution B, did not alter CV during control conditions or 15µM
CBX, which is unexpected based on previous works when [K+]o
was altered in a similar range (Kagiyama et al., 1982; Buchanan
et al., 1985). One important difference between this and previous
studies is that [Na+]o is reduced in Solution B relative to A.
The results show that CV is relatively insensitive to the changes
in [K+]o and [Na
+]o during normal and presumably low GJ
uncoupling (15µM CBX), with increased sensitivity at 30µM
CBX. These results are consistent with our data obtained in mice
with narrow perinexal widths and presumably increased EpC
(George et al., 2015).
The finding that increasing [K+]o in guinea pig myocardium
can slow conduction is consistent with the study of Pandit
et al. who found that dominant rotor frequencies are decreased,
suggesting slowed conduction, when [K+]o is increased from
4 to 7mM (Pandit et al., 2010). The intriguing finding that
increasing [K+]o in ventricular myocardium can increase CV
under certain conditions and decrease it under others is an
important future direction for research since increased [K+]o
is critically important to understanding electrical abnormalities
in diseases such as cardiac ischemia (Kagiyama et al., 1982;
Buchanan et al., 1985). Ischemia is also acutely associated with
acutely increased heart rate and collapse of the extracellular
space, and on a relatively longer time scale, loss of GJ coupling,
(Janse and Wit, 1989; Kostin et al., 2003; Severs et al., 2004)
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FIGURE 5 | Solution changes do not alter Cx43 expression or p368
phosphorylation. (A) Representative Western immunoblots of Cx43 with
alpha-tubulin as a loading control. (B) Quantification of total Cx43 expression
reveals no difference between hearts perfused with Solutions A or B.
(C) Representative Western immunoblots of Cx43-p368S and total Cx43 with
alpha-tubulin as a loading control. (D) Quantification of Cx43-p368S expression
reveals no difference between hearts perfused with Solutions A or B.
FIGURE 6 | Action potential duration measurements for all solution and
pacing rate combinations tested. Reducing BCL always shortened APD for
all solutions at every CBX concentration. *p < 0.025 between BCL. Solution B
significantly shortened APD relative to Solution A for all CBX concentrations.
†p < 0.025 between Solutions.
further highlighting the importance of understanding these
diverse modulators of cardiac conduction.
Increasing [K+]o and [Na
+]o have both been associated
with changes in ion channel kinetics. During hypokalemia for
example, peak current density of the inward rectifier potassium
current (IK1) is reduced, the slow component of the delayed
rectifier potassium current (IKs) is increased, and the rapid
component of the delayed rectifier potassium current (IKr)
is decreased (Scamps and Carmeliet, 1989; Sanguinetti and
Jurkiewicz, 1992). Additionally, co-transporters such as the Na-
K pump can be activated through a combination of [Na+]i and
[K+]o (Gadsby, 1984; Glitsch, 2001). Therefore, future studies
will be required to elucidate additional effects of other channels,
pumps, and exchangers on cardiac conduction.
FIGURE 7 | Rise Time measurements in both longitudinal and
transverse directions for all Solution and pacing rates. Pharmacologic
uncoupling with CBX progressively increased RT. †p < 0.025 relative to
control, *p < 0.025 between BCL.
Effects of Pacing Rate
It is well accepted that CV decreases when pacing rate increases,
due to sodium channel inactivation (Allouis et al., 2006;
Stein et al., 2011). Here, we demonstrated that reducing BCL
decreased CV depending on the solution composition and level
of pharmacologic GJ inhibition. Specifically, reducing BCL in
hearts perfused with Solution B with and without CBX decreased
CVL and CVT. The same effects were not always observed with
Solution A. Our previous research suggests that EpC can support
normal conduction when GJs are reduced (Veeraraghavan et al.,
2012, 2015; George et al., 2015). The finding that Solution A is
less sensitive to GJ uncoupling, suggests that Solution A may
promote EpC by maintaining sodium channel availability (lower
[K+]o) and increasing sodium driving force ([Na
+]o). Further,
even greater sodium channel inactivation by rapid pacing does
not significantly decrease CV even with GJ uncoupling sufficient
to reduce CV.
Effects of Gap Junctional Coupling
In the current study, increasing the concentration of CBX
appeared to progressively decrease CV. This agrees with
previous research which demonstrated that concentrations as
high as 15µM CBX do not significantly decrease CV, while
concentrations between 20 and 100µM CBX can decrease CV
(Spray et al., 2006; Veeraraghavan et al., 2012, 2015). According
to previous research, the IC50 of GJ inhibition by CBX is between
50 and 100µM (Ye et al., 2003; Bruzzone et al., 2005; Spray et al.,
2006; Suadicani et al., 2006). The observation that a significant
CV decrease secondary to CBX can be modulated by solution
composition and cardiac hydration further suggests that using
conduction velocity to estimate IC50 of CBXmay be complicated
by alternative modes of conduction.
It is also possible that ionic differences in solutions altered
Cx43 functional expression. However, the lack of a significant
total or Cx43-p368S change in Cx43 expression suggests, but does
not prove, that reported results are not due to GJ remodeling.
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Effects on Rise Time
Previous studies suggest that INa correlates with CV and that
the maximal rate of action potential upstroke rise (dV/dtmax)
is a correlate of peak INa. This is supported by studies which
demonstrated that decreasing INa,max can decrease dV/dtmax and
CV (Shaw and Rudy, 1997). Optical RT is an inverse correlate
of dV/dtmax (Spach et al., 1981; Poelzing and Rosenbaum, 2004;
Poelzing et al., 2004). The theory of cardiac conduction reserve
during GJ uncoupling suggests that RT should first decrease
during GJ uncoupling without a measurable effect on cardiac
conduction (Rudy and Quan, 1987; Cole et al., 1988; Shaw and
Rudy, 1997). We never observed such a relationship. In short, RT
either did not change with GJ uncoupling by CBX or it increased,
and this is consistent with other similar studies (Jalife et al., 1989;
Rohr et al., 1998). However, it is important to note that CBX is a
pharmacologic GJ uncoupler with off target effects, and this may
explain a lack of agreement with theoretical predictions.
Effects on Perinexal Width
Our group previously demonstrated that changing bulk
interstitial volume can modulate CV (Veeraraghavan et al., 2012,
2015). We also demonstrated that CV is inversely correlated
to perinexal width (George et al., 2015; Veeraraghavan et al.,
2015). In other words, increasing perinexal width can decrease
ventricular CV. To our knowledge, this is the first demonstration
that CBX can decrease perinexal width, which from previous
work should increase CV. An important difference in this study
compared to our previous manuscripts (Veeraraghavan et al.,
2012; George et al., 2015) is that changes in perinexal width in
this study were caused by pharmacological intervention with
CBX, instead of mannitol or altered calcium concentrations.
As changes in perinexal width due to CBX have never been
previously reported, it is difficult to discuss the mechanistic
link between perinexal width and CBX since this was also not
explored in this study. However, the relationship between CBX
and perinexal width may be related to a study by Goldberg et al.
demonstrating that glycyrrhetinic acid derivatives disrupt gap
junction plaques (Goldberg et al., 1996), which could alter the
structure of the perinexus. Therefore, these results suggest that
15µM CBX may promote EpC while simultaneously reducing
GJ coupling. By this mechanism, modest levels of CBX GJ
uncoupling may not alter CV.
Limitations
This study relies entirely upon using pacing protocols as well
as pharmacological GJ inhibitors. However, the findings that
altering [Na+]o and [K
+]o can modulate cardiac conduction
with pharmacologic inhibition is similar to findings in mice
heterozygous null for Cx43 (George et al., 2015). It will be
interesting to know in the future whether connexin targeting
peptides behave similarly to glycerhetinic acid derivatives.
It is well established that the electromechanical uncoupler
BDM can affect cardiac conduction, and may have therefore
confounded the results here. While this possibility cannot
be excluded, BDM was present for each experiment, and all
electrophysiologic comparisons were paired. However, perinexal
measurements were analyzed in an unpaired fashion, and BDM
may have altered these results. Yet, we previously demonstrated
that BDM does not change perinexal width relative to freshly
excised hearts (Veeraraghavan et al., 2015).
It has been shown that Cx43 localization can change due to
cardiac disease (Spragg et al., 2005; Spragg and Kass, 2006; Duffy,
2012). While we provide evidence that perinexal spacing was
only changed for samples that included CBX, alteration of Cx43
localization could account for some of the electrophysiological
changes that were seen. However, the effects quantified in this
study occurred in 10 or less minutes and were independent of
perfusion order. Therefore, it seems unlikely that Cx43 cellular
expression patterns were significantly altered on this time scale.
The mechanisms that underlie this atypical conduction
response to perfusate composition during GJ uncoupling could
be due to either altered cellular excitability (Kléber et al.,
1987a,b) around the entire myocyte or ephaptic mechanisms
(Veeraraghavan et al., 2012, 2015; George et al., 2015).
Importantly, the finding that conduction slowing secondary to
GJ uncoupling can be exacerbated by relatively small changes in
extracellular ions suggests that themechanism governing the CV-
GJ relationship is very sensitive to ionic perturbations within the
physiologic range, and this warrants additional investigation.
CONCLUSIONS
We present evidence that altering [K+]o, [Na
+]o, and heart rate
have important effects on GJ mediated conduction slowing. The
magnitude of ionic changes, while small, were in accordance with
the original hypothesis that the changes in [K+]o and [Na
+]o
would not substantially alter CV as previously demonstrated in
mice with normal Cx43 expression levels, but GJ uncoupling
can produce solution dependent CV changes. The implications
of this study are that relatively small physiologic changes in
extracellular ionic composition do not significantly perturb
cardiac electrophysiology under “normal” conditions, but these
same changes may have significant effects during cardiac stress as
a result of GJ remodeling or increased heart rate.
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